!!Gyorgy Bagdy - Selected list of publications
\\
__Cumulative impact factor:__>410\\
__Cumulative number of independent citations:__ >3200\\
__H-factor__=38
\\ \\
__Relevant publications including impact factors (if)  and number of citations (cit):__\\
\\
Kirilly E, Gonda X, Bagdy G: CB1 receptor antagonists: new discoveries leading to new perspectives, ACTA PHYSIOL (Oxford) 205: (1) 45-60, 2012. if:3.090, cit: 6\\
\\
Gyombolai P, Pap D, Turu G, Catt KJ, Bagdy G, Hunyady L: Regulation of endocannabinoid release by G proteins: A paracrine mechanism of G protein-coupled receptor action., MOL CELL ENDOCRINOL 353: (1-2) 29-36, 2012. if:4.192 cit:4\\
\\
Lazary J, Juhasz G, Hunyady L, Bagdy G: Personalized medicine can pave the way for the safe use of CB(1) receptor antagonists., TRENDS PHARMACOL SCI 32: (5) 270-280, 2011. if:10.927, cit:24\\
\\
Juhasz G, Downey D, Hinvest N, Thomas E, Chase D, Toth ZG, Lloyd-Williams K, Mekli K, Platt H, Payton A, Bagdy G, Elliott R, Deakin JFW, Anderson IM: Risk-Taking Behavior in a Gambling Task Associated with Variations in the Tryptophan Hydroxylase 2 Gene Relevance to Psychiatric Disorders, NEUROPSYCHOPHARMACOL 35: (5) 1109-1119, 2010. if:6.685, cit:16\\
\\
Turu G, Varnai P, Gyombolai P, Szidonya L, Offertaler L, Bagdy G, Kunos G, Hunyady L: Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors., J BIOL CHEM 284: (25) 16914-16921, 2009. if:5.328, cit:22\\
\\
Lazary J, Lazary A, Gonda X, Benko A, Molnar E, Hunyady L, Juhasz G, Bagdy G: Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype, AM J MED GENET B 150B: (8) 1118-1127, 2009 . if: 3.481, cit:20\\
\\
Lazary J, Lazary A, Gonda X, Benko A, Molnar E, Juhasz G, Bagdy G: New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype, BIOL PSYCHIAT 64: (6) 498-504, 2008. if:8.672, cit:51\\
\\
Bagdy G, Kecskeméti V, Riba P, Jakus R Serotonin and epilepsy. JOURNAL OF NEUROCHEMISTRY 100:(4) pp. 857-873. (2007). if: 4.45, cit:78\\
\\
Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S: Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635, INT J NEUROPSYCHOPH 4: (4) 399-408, 2001. if:2.779 cit:143\\
\\
BAGDY G, CALOGERO AE, MURPHY DL, SZEMEREDI K: SEROTONIN AGONISTS CAUSE PARALLEL ACTIVATION OF THE SYMPATHOADRENOMEDULLARY SYSTEM AND THE HYPOTHALAMO-PITUITARY-ADRENOCORTICAL AXIS IN CONSCIOUS RATS, ENDOCRINOLOGY 125: (5) 2664-2669, 1989. if:4.239 1cit:202